MyMD Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch MYMD and buy or sell other stocks, ETFs, and their options commission-free!

About MYMD

TNF Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the development of drug products to extend healthy lifespan. It focuses on developing two novel therapeutic platforms, MyMD-1 and SUPERA-CBD, which aim to treat the causes of disease rather than just addressing the symptoms. 

CEO
Christopher C. Chapman, Jr., MD
CEOChristopher C. Chapman, Jr., MD
Employees
2
Employees2
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1989
Founded1989
Employees
2
Employees2

MYMD Key Statistics

Market cap
9.55M
Market cap9.55M
Price-Earnings ratio
-0.02
Price-Earnings ratio-0.02
Dividend yield
—
Dividend yield—
Average volume
2.33M
Average volume2.33M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$3.37
52 Week high$3.37
52 Week low
$0.2106
52 Week low$0.2106
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.